Income sleeve — capped upside, variable payout. A 17.15% trailing distribution rate from Nasdaq-100 stocks with calls written on half the portfolio — the other half keeps its upside. Read the basis before the headline: $2.78 of the $5.02 trailing-12-month total was a single December 30, 2025 year-end distribution, so the recurring monthly run-rate is about 7.7%, not 17%. Monthly payouts vary with option premiums ($0.14 to $0.27 during 2026) — premium income, not earned dividends, and it is not steady.
Key risk: Variable premium income with half the upside sold — in a strong Nasdaq-100 rally the written calls cap half the gain, and in a quiet market premiums shrink and the monthly payout shrinks with them.
Changes if: Total return turns negative across a full cycle, or the recurring monthly run-rate falls well below the 2026 range — that moves it from an income sleeve toward a trap.
- !Coverage check: The payout is option premium plus underlying dividends, not earnings coverage: monthly amounts ranged from $0.1398 to $0.2679 in 2026, and the trailing total is flattered by a $2.78 year-end distribution.
- !Yield check: 17.15% headline — $5.02 over the trailing 12 months at the $29.26 close on Oct. 23, 2026 — but the recurring monthly run-rate is about 7.7% excluding the December 2025 year-end payout.
- !Growth-half check: Calls are written on only half the portfolio, so half the Nasdaq-100 upside is retained — better than a full buy-write, but half the gain is still sold away each month.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.